Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2014
05/08/2014WO2014071015A1 Erythroferrone and erfe polypeptides and methods of regulating iron metabolism
05/08/2014WO2014067505A2 Peptides that bind to amino-terminal truncated amyloid-beta-peptide and use of said peptides
05/08/2014WO2014067299A1 Bt toxin cry1ab-loop2-p2s having high toxicity against nilaparvata lungens and engineered bacterium
05/08/2014WO2014066936A1 Supramolecular structure
05/08/2014WO2013081471A3 Facile laboratory method for localising biomolecules to the surface of cells and viruses
05/08/2014WO2013056054A9 Peptide inhibitors of bace1
05/08/2014WO2012162547A3 Long duration dual hormone conjugates
05/08/2014US20140130209 Modified Plant Defensins Useful as Anti-Pathogenic Agents
05/08/2014US20140128328 Peptide antagonists of zonulin and methods for use of the same
05/08/2014US20140128321 Method and use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
05/08/2014US20140128313 Antimicrobial peptides and uses therefore
05/08/2014US20140128312 Antimicrobial lytic peptides
05/08/2014US20140128268 Methods of Constructing and Screening Libraries of Peptide Structures
05/08/2014US20140127269 Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof
05/08/2014US20140127245 Small Peptides And Methods For Treatment Of Chronic Obstructive Pulmonary Disease
05/08/2014US20140127214 Natural igm antibodies and inhibitors thereof
05/08/2014DE102012110664A1 In Beschichtungsmitteln, Haftvermittlern oder Klebstoffen für oxidische Oberflächen einsetzbare Peptide In coatings, bonding agents or adhesives for oxidic surfaces can be used peptides
05/07/2014EP2727601A1 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
05/07/2014EP2726882A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof
05/07/2014EP2726501A1 Sulfation of wnt pathway proteins
05/07/2014CN103781797A β转导素重复包含蛋白的结合抑制剂 β transducin repeat containing protein binding inhibitors
05/07/2014CN103772492A 核因子-kb多肽抑制剂4及其应用 -kb Peptide inhibitor of nuclear factor-4 and Its Applications
05/07/2014CN103772491A 核因子-kb多肽抑制剂3及其应用 -kb Peptide inhibitor of nuclear factor-3 and Its Applications
05/07/2014CN103772490A 一种地衣芽孢杆菌分泌的抗菌肽及其制备方法和应用 An antimicrobial peptide from Bacillus its preparation method and application secretion
05/07/2014CN103772489A 核因子-kb多肽抑制剂5及其应用 -kb Peptide inhibitor of nuclear factor-5 and its application
05/07/2014CN103772488A 聚乙二醇修饰的血管内皮生长因子受体2酪氨酸激酶多肽抑制剂多肽及其应用 Polyethylene glycol-modified vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor peptides and polypeptides Applications
05/07/2014CN103772487A 一种抑制人胰淀素聚集或毒性的多肽、试剂及其应用 An aggregation of human amylin or toxic peptide reagents and suppression
05/07/2014CN103145811B 一种合成阿拉泊韦的方法 A method for the synthesis of Allah poise Wei
05/07/2014CN102898510B 一种分离恩拉霉素a和恩拉霉素b的方法 A enramycin a and b enramycin method for separating
05/07/2014CN102617710B 人类新基因famlf特异性抗体的新增免疫表位及抗体制备与应用 Human Gene famlf new immunodominant epitope-specific antibodies and antibody preparation and application
05/07/2014CN102516359B 一种抗老年痴呆症先导化合物 A lead compound for anti-Alzheimer's disease
05/07/2014CN102516355B 一种苯并呋喃喹啉的肽类衍生物及其制备方法和作为抗肿瘤药物的应用 One kind of benzofuran quinoline derivative peptides and preparation method and application as anticancer drugs
05/07/2014CN102485746B 具有靶向性溶血栓活性的寡肽、其制备方法和应用 Oligopeptide has targeted thrombolytic activity, their preparation and use
05/07/2014CN102391362B 一组动物源性阳离子抗菌肽及其应用 A group of animal-derived cationic antimicrobial peptides and their application
05/07/2014CN102202679B 环十一缩酚酸肽化合物及其作为药物的用途 Cyclic depsipeptide compounds XI and their use as medicament
05/07/2014CN102112487B 制备卡泊芬净及其中间体的方法 Preparation of caspofungin and its intermediate approach
05/07/2014CN101636169B 自组装两性分子聚合物为抗病毒剂 Self-assembling amphiphilic polymers for antivirals
05/06/2014US8716472 Tripodal cyclohexane derivatives and their use as carbohydrate receptors
05/06/2014US8716438 Matricryptic ECM peptides for tissue reconstruction
05/06/2014US8716436 Mu opioid receptor agonist analogs of the endomorphins
05/06/2014US8716247 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/06/2014US8716246 Azuvirin peptides
05/06/2014US8716245 Tissue protective peptides and uses thereof
05/06/2014US8716242 β-hairpin peptidomimetics
05/06/2014US8716234 Cytotoxins comprising modified bouganin toxin for the treatment of cancer
05/06/2014US8716232 Use of endostatin peptides for the treatment of fibrosis
05/06/2014US8715685 Stereoisomer peptides and their polymer conjugates for HIV disease
05/06/2014US8715682 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
05/06/2014CA2743731C Method of modulating the proliferation of medullary thyroid carcinoma cells
05/06/2014CA2631292C Derivatised wt1 cancer antigen peptides and their use
05/06/2014CA2508696C Process for the preparation of bicyclic peptide compounds
05/01/2014WO2014065017A1 Artificial blood vessel, and method for producing artificial blood vessel
05/01/2014WO2014035828A3 Inhibition of axl signaling in anti-metastatic therapy
05/01/2014WO2014014613A3 Self-assembling peptides, peptide nanostructures and uses thereof
05/01/2014US20140121170 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
05/01/2014US20140121169 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
05/01/2014US20140121168 Antagonists of trpv1 receptor
05/01/2014US20140121165 Induction of the Mitochondrial Permeability Transition
05/01/2014US20140121153 Novel polypeptides
05/01/2014US20140120141 Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
04/2014
04/30/2014EP2723762A1 Binding inhibitors of the beta.transducin repeat - containing protein
04/30/2014EP2723761A1 Compound and method for modulating opioid receptor activity
04/30/2014EP2723387A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
04/30/2014EP2723360A1 Ccr2 antagonist peptides
04/30/2014CN103764672A Process of preparing guanylate cyclase C agonists
04/30/2014CN103764668A Leukemia stem cell targeting ligands and methods of use
04/30/2014CN103764666A A process for extraction of peptides and its application in liquid phase peptide synthesis
04/30/2014CN103755843A N-9-fluorenylmethoxycarbonyl hydrazine base resin, preparation method and application thereof
04/30/2014CN103755788A Polypeptide for inhibiting immune globulin K light-chain gene enhancer protein and application thereof
04/30/2014CN103755787A New assays for preimplantation factor and preimplantation factor peptides
04/30/2014CN103755786A Melanocortin receptor ligands
04/30/2014CN102898508B Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application
04/30/2014CN102863518B Polymyxin B compound and preparation method thereof
04/30/2014CN102212111B Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
04/30/2014CN101885758B Auto-antigen epitope and encoding gene and application thereof
04/30/2014CN101848926B Peptide capable of binding to immunoglobulin
04/30/2014CN101573373B Cyclic angiotensin analogs
04/29/2014US8710183 Inhibitors of bacterial tyrosine kinase and uses thereof
04/29/2014US8710181 Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
04/29/2014US8710180 VEGF-specific capture agents, compositions, and methods of using and making
04/29/2014US8710179 Compositions and methods for concentrating and depleting microorganisms
04/29/2014US8710017 Human and mouse targeting peptides identified by phage display
04/29/2014US8710014 Compositions and methods for inhibition of MMP13:MMP-substrate interactions
04/29/2014US8710011 Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
04/29/2014US8709998 Peptide vectors
04/29/2014US8709779 Newly identified human rhinovirus of HRV-C and methods and kits for detecting HRV-Cs
04/24/2014WO2014063147A1 New antiviral macrocycles
04/24/2014WO2014061772A1 Novel nk3 receptor agonist
04/24/2014WO2014060601A1 Compositions and methods for drug delivery
04/24/2014WO2014059928A1 Anticancer and anti-obesity cyclic peptide agents
04/24/2014WO2014059530A1 Derivatives of collagen-binding hairpin peptides
04/24/2014US20140114050 Use of peptides for promoting wound healing
04/24/2014US20140113874 Modified Compstatin With Improved Stability And Binding Properties
04/24/2014US20140113858 Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof
04/24/2014US20140112976 Cyclic Peptides with an Anti-Neoplasic and Anti-Angiogenic Activity
04/24/2014US20140112947 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor
04/24/2014US20140112873 Melanocortin 1 receptor ligands and methods of use
04/23/2014EP2722336A1 Vaccine for the prevention of breast cancer relapse
04/23/2014EP2722060A2 Guanylyl cyclase C ligands
04/23/2014EP2722051A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 423